Literature DB >> 28149556

Effect of gender on perioperative outcomes after robotic-assisted pulmonary lobectomy.

Jessica R Glover1, Frank O Velez-Cubian2, Wei Wei Zhang2, Kavian Toosi1, Tawee Tanvetyanon3, Emily P Ng1, Carla C Moodie3, Joseph R Garrett3, Jacques P Fontaine4, Eric M Toloza4.   

Abstract

BACKGROUND: Female gender has been associated with worse outcomes after cardiovascular surgery and critical illness. We investigated the effect of gender on perioperative outcomes following robotic-assisted pulmonary lobectomy.
METHODS: We retrospectively analyzed 282 consecutive patients who underwent robotic-assisted pulmonary lobectomy by one surgeon over 53 months. Perioperative outcomes and clinically significant intraoperative and postoperative complications, including respiratory and cardiovascular events, were noted. Chi-Square (χ2), Fisher's exact test, Analysis of Variance (ANOVA), Student's t-test, and Kruskal-Wallis or Mood's median test were used to compare variables, with significance at P≤0.05.
RESULTS: There were 128 men (mean age, 68.8 yr) and 154 women (mean age, 65.9 yr; P=0.02). Women had higher preoperative forced expiratory volume in 1 second as percent of predicted (FEV1%; P=0.001). There were more former smokers in the male cohort (P=0.03) and more nonsmokers in the female cohort (P<0.001). Women had smaller tumors (3.0±0.1 vs. 3.5±0.2 cm, P=0.04), lower estimated blood loss (EBL) (150±34 vs. 250±44 mL, P<0.001), and shorter operative time (168±6 vs. 196±7 min, P=0.01). Rates of intraoperative complications (7.1% vs. 8.6%, P=0.65) and of conversion to open lobectomy (7.8% vs. 8.6%; P=0.81) were similar between genders. Postoperative complications were fewer in women (27.9% vs. 44.5%; P=0.004), the most common of which, in both women and men, were prolonged air leak for ≥7 days (13.0% vs. 22.7%, P=0.03), atrial fibrillation (7.1% vs. 14.8%, P=0.04), and pneumonia (7.8% vs. 10.2%, P=0.49). Hospital length of stay (LOS) (4±0.3 vs. 5±0.5 days) was also shorter for women (P=0.02). Despite the higher postoperative complication rate in men, in-hospital mortality did not differ between genders (P=0.23). Multivariable analyses did not identify female gender as an independent predictor of post-operative complications.
CONCLUSIONS: Female gender was associated with rates of intraoperative complications and of conversion to open lobectomy as low as those for men, but with better perioperative outcomes, lower risk of intraoperative bleeding, and fewer postoperative complications. Thus, robotic-assisted pulmonary lobectomy is feasible and safe for women.

Entities:  

Keywords:  Gender; lobectomy; lung cancer; outcomes; robotic

Year:  2016        PMID: 28149556      PMCID: PMC5227215          DOI: 10.21037/jtd.2016.12.11

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  36 in total

Review 1.  Female gender is an independent prognostic factor in non-small-cell lung cancer: a meta-analysis.

Authors:  Haruhiko Nakamura; Koji Ando; Takuo Shinmyo; Katsuhiko Morita; Atsushi Mochizuki; Noriaki Kurimoto; Shinobu Tatsunami
Journal:  Ann Thorac Cardiovasc Surg       Date:  2011-07-27       Impact factor: 1.520

2.  Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update.

Authors:  Gillian Bethune; Drew Bethune; Neale Ridgway; Zhaolin Xu
Journal:  J Thorac Dis       Date:  2010-03       Impact factor: 2.895

3.  The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years.

Authors:  Roy Båtevik; Ketil Grong; Leidulf Segadal; Lodve Stangeland
Journal:  Lung Cancer       Date:  2005-02       Impact factor: 5.705

4.  Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer.

Authors:  Mark F Berry; Chi-Fu Jeffrey Yang; Matthew G Hartwig; Betty C Tong; David H Harpole; Thomas A D'Amico; Mark W Onaitis
Journal:  Ann Thorac Surg       Date:  2015-05-16       Impact factor: 4.330

5.  Supraventricular arrhythmia following lung resection for non-small cell lung cancer and its treatment with amiodarone.

Authors:  P Ciriaco; P Mazzone; B Canneto; P Zannini
Journal:  Eur J Cardiothorac Surg       Date:  2000-07       Impact factor: 4.191

Review 6.  Women and lung cancer: what is new?

Authors:  Crystal M North; David C Christiani
Journal:  Semin Thorac Cardiovasc Surg       Date:  2013

Review 7.  Diabetes Mellitus and Risk of Bronchopleural Fistula After Pulmonary Resections: A Meta-Analysis.

Authors:  Shuang-Jiang Li; Jun Fan; Jian Zhou; Yu-Tao Ren; Cheng Shen; Guo-Wei Che
Journal:  Ann Thorac Surg       Date:  2016-04-08       Impact factor: 4.330

8.  Sex differences in early outcomes after lung cancer resection: analysis of the Society of Thoracic Surgeons General Thoracic Database.

Authors:  Betty C Tong; Andrzej S Kosinski; William R Burfeind; Mark W Onaitis; Mark F Berry; David H Harpole; Thomas A D'Amico
Journal:  J Thorac Cardiovasc Surg       Date:  2014-03-14       Impact factor: 5.209

9.  Sociodemographic factors and delays in the diagnosis of six cancers: analysis of data from the "National Survey of NHS Patients: Cancer".

Authors:  R D Neal; V L Allgar
Journal:  Br J Cancer       Date:  2005-06-06       Impact factor: 7.640

10.  Air leaks following pulmonary resection for lung cancer: is it a patient or surgeon related problem?

Authors:  H Elsayed; J McShane; M Shackcloth
Journal:  Ann R Coll Surg Engl       Date:  2012-09       Impact factor: 1.891

View more
  2 in total

1.  Risk Factors and In-Hospital Outcomes of Perioperative Atrial Fibrillation for Patients with Cancer: A Meta-Analysis.

Authors:  Keiko Inoue; Kazuko Tajiri; DongZhu Xu; Nobuyuki Murakoshi; Masaki Ieda
Journal:  Ann Surg Oncol       Date:  2022-10-22       Impact factor: 4.339

2.  Enhanced longevity and metabolism by brown adipose tissue with disruption of the regulator of G protein signaling 14.

Authors:  Dorothy E Vatner; Jie Zhang; Marko Oydanich; John Guers; Elena Katsyuba; Lin Yan; David Sinclair; Johan Auwerx; Stephen F Vatner
Journal:  Aging Cell       Date:  2018-04-14       Impact factor: 9.304

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.